生命科学资讯

House backs Biosecure Act aimed at Chinese companies

Investors buy up stocks in biggest follow-on offering day in biotech history

Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backer

USAntibiotics scores sped-up approval for amoxicillin

Adare Pharma shutters Philadelphia site and lays off over 100 staffers

In a first, FDA approves a gene therapy from a nonprofit

J&J joins 'menin party' at ASH; GSK to work with Oxford BioTherapeutics

#SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%

PsiThera gets $47.5M for oral I&I drugs after spinning out from Roivant

Formation Bio signs deal for TYK2 drug from China's Lynk

UK lowers new medicine rebate scheme to 14.5% for 2026

D3 Bio raises $108M to take next-gen KRAS G12C drug into Phase 3

BlossomHill gets another $84M for macrocyclic approach to EGFR

FDA is taking another look at safety of approved RSV antibodies

Eli Lilly earmarks $6B for GLP-1 pill factory in Alabama

FDA's probe of Covid-19 vaccines expands into adults

#ASH25: New data from Gilead, J&J set up a bispecific, CAR-T rivalry

J&J-backed Cellular Origins raises $40M for cell therapy manufacturing

SanegeneBio raises $110M in follow-up to metabolic deal with Lilly

Novartis to partner with AI-focused Relation on atopic diseases